Comparison of intravenous to oral trovafloxacin vs intravenous imipenem/cilastatin to oral amoxicillin/clavulanic acid in complicated intra-abdominal infections

被引：1
|
作者：
Luke, DR [1 ]
机构：
[1] Pfizer Inc, Pfizer Cent Res, Groton, CT 06340 USA
来源：
DRUGS | 1999年 / 58卷 / Suppl 2期
关键词：
D O I：
10.2165/00003495-199958002-00099
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：295 / 297
页数：3
相关论文
共 50 条
  • [1] Comparison of Intravenous to Oral Trovafloxacin vs Intravenous Imipenem/Cilastatin to Oral Amoxicillin/Clavulanic Acid in Complicated Intra-Abdominal Infections
    D. R. Luke
    Drugs, 1999, 58 : 295 - 297
  • [2] Treatment of complicated intra-abdominal infections: Comparison of intravenous/oral trovafloxacin versus IV imipenem/cilastatin switching to oral amoxycillin/clavulanic acid
    Luke, DR
    Peterson, J
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, 53 (03) : 166 - +
  • [3] Trovafloxacin in the treatment of intra-abdominal infections: Results of a double blind, multicenter comparison with imipenem/cilastatin
    Donahue, PE
    Smith, DL
    Yellin, AE
    Mintz, SJ
    Bur, F
    Luke, DR
    AMERICAN JOURNAL OF SURGERY, 1998, 176 (06): : 53S - 61S
  • [4] Results of a randomized trial comparing sequential intravenous oral treatment with ciprofloxacin plus metronidazole to imipenem cilastatin for intra-abdominal infections
    Solomkin, JS
    Reinhart, HH
    Dellinger, EP
    Bohnen, JM
    Rotstein, OD
    Vogel, SB
    Simms, HH
    Hill, CS
    Bjornson, HS
    Haverstock, DC
    Coulter, HO
    Echols, RM
    ANNALS OF SURGERY, 1996, 223 (03) : 303 - 315
  • [5] Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections
    R. Vick-Fragoso
    G. Hernández-Oliva
    J. Cruz-Alcázar
    C. F. Amábile-Cuevas
    P. Arvis
    P. Reimnitz
    J. R. Bogner
    Infection, 2009, 37 : 407 - 417
  • [6] Efficacy and Safety of Sequential Intravenous/Oral Moxifloxacin vs Intravenous/Oral Amoxicillin/Clavulanate for Complicated Skin and Skin Structure Infections
    Vick-Fragoso, R.
    Hernandez-Oliva, G.
    Cruz-Alcazar, J.
    Amabile-Cuevas, C. F.
    Arvis, P.
    Reimnitz, P.
    Bogner, J. R.
    INFECTION, 2009, 37 (05) : 407 - 417
  • [7] A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections
    Angeras, MH
    Darle, N
    Hamnstrom, K
    Ekelund, M
    Engstrom, L
    Takala, J
    Viste, A
    Holme, JB
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1996, 28 (05) : 513 - 518
  • [8] Results of a prospective, randomized, double blind comparison of the efficacy and the safety of sequential ciprofloxacin (intravenous/oral) plus metronidazole (intravenous/oral) with ceftriaxone (intravenous) plus metronidazole (intravenous/oral) for the treatment of intra-abdominal infections
    Starakis, I
    Karravias, D
    Asimakopoulos, C
    Kolaras, P
    Nikolaidis, P
    Harlaftis, N
    Skoutelis, A
    Bassaris, H
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 21 (01) : 49 - 57
  • [9] Imipenem/cilastatin sodium/relebactam fixed combination to treat urinary infections and complicated intra-abdominal bacterial infections
    Thakare, R.
    Dasgupta, A.
    Chopra, S.
    DRUGS OF TODAY, 2020, 56 (04) : 241 - 255
  • [10] Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial
    Chen, Zhangjing
    Wu, Jufang
    Zhang, Yingyuan
    Wei, Junming
    Leng, Xisheng
    Bi, Jianwei
    Li, Rong
    Yan, Lunan
    Quan, Zhiwei
    Chen, Xiaoping
    Yu, Yunsong
    Wu, Zhiyong
    Liu, Dawei
    Ma, Xiaochun
    Maroko, Robert
    Cooper, Angel
    BMC INFECTIOUS DISEASES, 2010, 10
12345